Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 3
This trial is comparing chemotherapy with MK-2870 for non small cell lung cancer (NSCLC).
It is for people whose cancer has certain gene changes () in the lung cancer cells and:
the cancer has spread into nearby tissues and it isn't possible to treat it with surgery or radiotherapy or
the cancer has spread to another part of the body
Recruitment start: 3 July 2024
Recruitment end: 7 April 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Adam Januszewski
Merck Sharp & Dohme Ltd
Last reviewed: 29 Apr 2026
CRUK internal database number: 19877
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
